Burkholderia pseudomallei activates complement and is ingested but not killed by polymorphonuclear leukocytes.

Infection and Immunity
A M Egan, D L Gordon

Abstract

The mechanism by which Burkholderia pseudomallei is resistant to lysis by human serum is unknown but may include interference with complement activation, effective opsonization, or complement-mediated lysis. We investigated the interaction of B. pseudomallei with complement in the presence and absence of specific antibody to determine potential mechanisms of serum resistance. We demonstrated rapid activation and consumption of complement by B. pseudomallei which, in the absence of specific antibody, occurred predominantly via the alternative pathway. Complement activation was associated with deposition of the opsonically active C3b and iC3b fragments on the bacterial surface. C5b-9, detected on the bacterial surface after opsonic periods of 1 to 60 min, was susceptible to elution by 1 M NaCl, indicating that resistance to complement-mediated lysis may result from deposition of the membrane attack complex in a nonmicrobicidal location. To define the role of opsonins, we investigated the ability of polymorphonuclear leukocytes (PMNL) to phagocytose B. pseudomallei. Phagocytosis of bacteria by PMNL, and the observed oxidative response, was significantly increased by opsonization of organisms with complement and/or specific antibod...Continue Reading

References

May 1, 1979·Journal of Clinical Pathology·L R Ashdown
Jan 1, 1991·Clinical Microbiology Reviews·D A Dance
Mar 1, 1991·Immunology Today·B F Hall, K A Joiner
Feb 1, 1990·Journal of Medical Microbiology·S PruksachartvuthiK Thankerngpol
Sep 23, 1989·Lancet·N J WhiteN Pitakwatchara
May 1, 1989·Reviews of Infectious Diseases·A Leelarasamee, S Bovornkitti
Aug 1, 1989·The Journal of Infectious Diseases·L R AshdownC A Cooney
Jan 1, 1988·Annual Review of Microbiology·K A Joiner
Jan 1, 1988·Microbiology and Immunology·G IsmailO Omar
Apr 1, 1988·The Journal of Infectious Diseases·D L GordonM K Hostetter
Nov 1, 1987·The Journal of Experimental Medicine·N R Payne, M A Horwitz
Sep 1, 1985·Microbiological Reviews·J W Moulder
Jan 1, 1984·Annual Review of Immunology·K A JoinerM M Frank
May 1, 1984·The American Journal of Tropical Medicine and Hygiene·L R Ashdown, R W Guard
Dec 1, 1994·Infection and Immunity·S MerinoJ M Tomás
Jun 1, 1993·Journal of Clinical Microbiology·P M DesmarchelierT L Pitt
Oct 1, 1993·Infection and Immunity·D E WoodsP J Hill
Jan 1, 1995·Histopathology·K T WongJ Vadivelu
Mar 1, 1996·Infection and Immunity·A L JonesD E Woods

❮ Previous
Next ❯

Citations

Oct 26, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B J CurrieV L Krause
Apr 16, 2002·Internal Medicine Journal·D P StephensB J Currie
Nov 19, 2004·Tropical Medicine & International Health : TM & IH·Bart J CurrieVicki L Krause
Apr 16, 2005·Clinical Microbiology Reviews·Allen C Cheng, Bart J Currie
Oct 29, 2008·Infection and Immunity·Sujin ChanchamroenGanjana Lertmemongkolchai
Feb 10, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·W Joost WiersingaTom van der Poll
Mar 24, 2012·Clinical and Vaccine Immunology : CVI·Apichaya PuangpetchSurasakdi Wongratanacheewin
Jan 9, 2014·Critical Care Medicine·Liesbeth M KagerTom van der Poll
Jan 5, 2002·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·John NorthfieldIain A M MacPhee
Sep 18, 2004·Clinical and Experimental Immunology·P UtaisincharoenS Sirisinha
Feb 25, 2005·Antimicrobial Agents and Chemotherapy·Kang ChenYunn-Hwen Gan
Feb 2, 2018·Nature Reviews. Disease Primers·W Joost WiersingaDirek Limmathurotsakul
Mar 17, 2006·Nature Reviews. Microbiology·W Joost WiersingaSharon J Peacock
Dec 13, 2006·Microbiology·Putthapoom LumjiaktaseMongkol Kunakorn
Oct 23, 2013·PLoS Neglected Tropical Diseases·Gavin C K W KohW Joost Wiersinga
Mar 26, 2003·Infection and Immunity·K L ChuaY H Gan
May 12, 2017·PLoS Neglected Tropical Diseases·Ramar Perumal SamyLina H K Lim
Feb 15, 2001·FEMS Immunology and Medical Microbiology·Y P GauthierD R Vidal
Sep 30, 1998·FEMS Immunology and Medical Microbiology·G C UlettR G Hirst
Dec 14, 1999·Microbes and Infection·D E WoodsM D Senkiw
May 18, 2000·Microbes and Infection·R Rautemaa, S Meri

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.